Pulmonx Corp. LUNG
NASDAQ · United States · Health Technology
$1.83-0.08 (-4.19%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-29 | -0.24 | -0.28 | +14.3% | $22.76M | +1.6% | +28.8%$1.25→$1.61 |
| Q1 2026 | 2026-04-29 | -0.33 | -0.33 | 0.0% | — | — | +4.1%$1.23→$1.28 |
| Q4 2025 | 2026-03-04 | -0.25 | -0.38 | +34.2% | — | — | +5.2%$1.53→$1.61 |
| Q3 2025 | 2025-11-12 | -0.34 | -0.40 | +15.0% | — | — | -23.9%$2.09→$1.59 |
| Q3 2023 | 2023-10-30 | -0.39 | -0.43 | +9.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.